169 related articles for article (PubMed ID: 30374718)
1. Heat processing effect of luteolin on anti-metastasis activity of human glioblastoma cells U87.
El Gueder D; Maatouk M; Kalboussi Z; Daouefi Z; Chaaban H; Ioannou I; Ghedira K; Ghedira LC; Luis J
Environ Sci Pollut Res Int; 2018 Dec; 25(36):36545-36554. PubMed ID: 30374718
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
3. Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis.
Mokdad-Bzeouich I; Kovacic H; Ghedira K; Chebil L; Ghoul M; Chekir-Ghedira L; Luis J
Tumour Biol; 2016 Mar; 37(3):3657-64. PubMed ID: 26459313
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Chakrabarti M; Ray SK
Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
[TBL] [Abstract][Full Text] [Related]
5. Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma.
Wang Q; Wang H; Jia Y; Pan H; Ding H
Cancer Chemother Pharmacol; 2017 May; 79(5):1031-1041. PubMed ID: 28393257
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin B purified from Ecballium elaterium (L.) A. Rich from Tunisia inhibits α5β1 integrin-mediated adhesion, migration, proliferation of human glioblastoma cell line and angiogenesis.
Touihri-Barakati I; Kallech-Ziri O; Ayadi W; Kovacic H; Hanchi B; Hosni K; Luis J
Eur J Pharmacol; 2017 Feb; 797():153-161. PubMed ID: 28108377
[TBL] [Abstract][Full Text] [Related]
7. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
8. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
9. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
10. Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity.
Cheng WY; Chiao MT; Liang YJ; Yang YC; Shen CC; Yang CY
Mol Biol Rep; 2013 Sep; 40(9):5315-26. PubMed ID: 23677714
[TBL] [Abstract][Full Text] [Related]
11. Anti-Proliferative Potential of Cynaroside and Orientin-In Silico (DYRK2) and In Vitro (U87 and Caco-2) Studies.
Pirvu LC; Pintilie L; Albulescu A; Stefaniu A; Neagu G
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068880
[TBL] [Abstract][Full Text] [Related]
12. Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis.
Wang J; Liu K; Wang XF; Sun DJ
Oncol Rep; 2017 Oct; 38(4):1959-1966. PubMed ID: 28791366
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
14. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs.
Sun DW; Zhang HD; Mao L; Mao CF; Chen W; Cui M; Ma R; Cao HX; Jing CW; Wang Z; Wu JZ; Tang JH
Cell Physiol Biochem; 2015; 37(5):1693-711. PubMed ID: 26545287
[TBL] [Abstract][Full Text] [Related]
15. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
16. Luteolin Decreases Epidermal Growth Factor Receptor-Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell Lines.
Anson DM; Wilcox RM; Huseman ED; Stump TA; Paris RL; Darkwah BO; Lin S; Adegoke AO; Gryka RJ; Jean-Louis DS; Amos S
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):678-686. PubMed ID: 29935053
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Rooprai HK; Kandanearatchi A; Maidment SL; Christidou M; Trillo-Pazos G; Dexter DT; Rucklidge GJ; Widmer W; Pilkington GJ
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):29-39. PubMed ID: 11299000
[TBL] [Abstract][Full Text] [Related]
18. Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma.
Viswanathan A; Zhurina A; Assoah B; Paakkunainen A; Musa A; Kute D; Saravanan KM; Yli-Harja O; Candeias NR; Kandhavelu M
Eur J Pharmacol; 2018 Oct; 837():105-116. PubMed ID: 30179612
[TBL] [Abstract][Full Text] [Related]
19. Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function.
Wan B; Wu Z; Zhang X; Huang B
Biochem Biophys Res Commun; 2021 Nov; 580():7-13. PubMed ID: 34607260
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
